- Home
- BIVI vs BLAC Comparison
BIVI vs BLAC Comparison
Compare BIVI & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- BLAC
- Stock Information
- Founded
- BIVI 2013
- BLAC 2020
- Country
- BIVI United States
- BLAC United States
- Employees
- BIVI N/A
- BLAC N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- BLAC
- Sector
- BIVI Health Care
- BLAC
- Exchange
- BIVI Nasdaq
- BLAC NYSE
- Market Cap
- BIVI 45.1M
- BLAC 44.6M
- IPO Year
- BIVI N/A
- BLAC 2023
- Fundamental
- Price
- BIVI $3.11
- BLAC $11.62
- Analyst Decision
- BIVI Strong Buy
- BLAC
- Analyst Count
- BIVI 2
- BLAC 0
- Target Price
- BIVI $40.00
- BLAC N/A
- AVG Volume (30 Days)
- BIVI 3.3M
- BLAC 5.8K
- Earning Date
- BIVI 11-13-2024
- BLAC 01-01-0001
- Dividend Yield
- BIVI N/A
- BLAC N/A
- EPS Growth
- BIVI N/A
- BLAC N/A
- EPS
- BIVI N/A
- BLAC N/A
- Revenue
- BIVI N/A
- BLAC N/A
- Revenue This Year
- BIVI N/A
- BLAC N/A
- Revenue Next Year
- BIVI N/A
- BLAC N/A
- P/E Ratio
- BIVI N/A
- BLAC N/A
- Revenue Growth
- BIVI N/A
- BLAC N/A
- 52 Week Low
- BIVI $1.04
- BLAC $10.43
- 52 Week High
- BIVI $56.54
- BLAC $13.40
- Technical
- Relative Strength Index (RSI)
- BIVI 56.34
- BLAC 59.49
- Support Level
- BIVI $2.87
- BLAC $11.57
- Resistance Level
- BIVI $3.85
- BLAC $12.96
- Average True Range (ATR)
- BIVI 0.39
- BLAC 0.46
- MACD
- BIVI 0.01
- BLAC 0.05
- Stochastic Oscillator
- BIVI 51.32
- BLAC 25.52
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About BLAC BELLEVUE LIFE SCIENCES ACQ CORP
Bellevue Life Sciences Acquisition Corp is a blank check company.